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Researcher Receives Second
Patent for Device to Provide
Relief from Glaucoma
Khalid Lafdi, University of Dayton Wright Brothers Endowed
Chair in Nanomaterials, was named on a second patent for a
medical drainage device mainly for glaucoma patients that
also could be used for drainage in the ears, brain or chest or
to provide access to larger veins or arteries.
Glaucoma a ects more than 3 million Americans, according
to the Glaucoma Research Foundation. It occurs when the
eye stops naturally draining  uid and the resulting increased
intraocular pressure damages the optic nerves in the eye.
The device Lafdi created with UD graduate Edward Timm,
CEO of Mobius Therapeutics LLC, prevents the growth of
 broblasts that encapsulate and block drainage devices.
Previous versions of the device made of silicon increase
 broblasts.
"Silicone itself actually stimulates the growth of  broblasts
and results in the dysfunction of silicone glaucoma drainage
devices," said Timm.  
Lafdi and Timm designed the drain tube using Lafdi's "fuzzy
 ber," a sca old of carbon — also highly biocompatible —
covered with surface-treated carbon nanotubes grown in a
highly controlled manner, giving the material its fuzzy
appearance, according to Lafdi.
"The  rst patent protected drainage devices constructed
entirely with Lafdi's carbon-based material. This second
patent protects existing devices coated with the material,"
Timm said. "Therefore, we can con gure more  exible,
optimal devices for the eye and then coat them in the
material that prohibits  broblasts."
Mobius is negotiating non-exclusive rights to the coating
with multiple parties at this time, according to Timm.




















Click here to read about the breakthrough that led to the
 rst "fuzzy  ber" patent.
For interviews, contact Shawn Robinson, associate director
of news and communications, at 937-229-3391 or
srobinson1@udayton.edu.
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